South Dakota Investment Council Acorda Therapeutics Inc Transaction History

South Dakota Investment Council

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$3.61 - $5.23 $3 - $5	-1 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$3.8 - $8.04 $22,416 - $47,427	-5,899 Reduced 99.98%	1 $0
Q4 2020 Feb 12, 2021	BUY	$3.12 - $6.6 $18,408 - $38,940	5,900 New	5,900 $4,000

133K

Ticker ACOR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 24,338,400
Market Cap $6.33M
Description
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

Stay updated on South Dakota Investment Council with notifications on news.